480 related articles for article (PubMed ID: 28363951)
1. Heterotrimeric G proteins in the control of parathyroid hormone actions.
Bastepe M; Turan S; He Q
J Mol Endocrinol; 2017 May; 58(4):R203-R224. PubMed ID: 28363951
[TBL] [Abstract][Full Text] [Related]
2. Disruption of β-catenin binding to parathyroid hormone (PTH) receptor inhibits PTH-stimulated ERK1/2 activation.
Yang Y; Wang B
Biochem Biophys Res Commun; 2015 Aug; 464(1):27-32. PubMed ID: 26047699
[TBL] [Abstract][Full Text] [Related]
3. The G protein α subunit variant XLαs promotes inositol 1,4,5-trisphosphate signaling and mediates the renal actions of parathyroid hormone in vivo.
He Q; Zhu Y; Corbin BA; Plagge A; Bastepe M
Sci Signal; 2015 Aug; 8(391):ra84. PubMed ID: 26307011
[TBL] [Abstract][Full Text] [Related]
4. Loss of Gsα in the Postnatal Skeleton Leads to Low Bone Mass and a Blunted Response to Anabolic Parathyroid Hormone Therapy.
Sinha P; Aarnisalo P; Chubb R; Poulton IJ; Guo J; Nachtrab G; Kimura T; Swami S; Saeed H; Chen M; Weinstein LS; Schipani E; Sims NA; Kronenberg HM; Wu JY
J Biol Chem; 2016 Jan; 291(4):1631-1642. PubMed ID: 26598522
[TBL] [Abstract][Full Text] [Related]
5. Parathyroid hormone (PTH) and PTH-related peptide domains contributing to activation of different PTH receptor-mediated signaling pathways.
Cupp ME; Nayak SK; Adem AS; Thomsen WJ
J Pharmacol Exp Ther; 2013 Jun; 345(3):404-18. PubMed ID: 23516330
[TBL] [Abstract][Full Text] [Related]
6. Bone mineralization is regulated by signaling cross talk between molecular factors of local and systemic origin: the role of fibroblast growth factor 23.
Sapir-Koren R; Livshits G
Biofactors; 2014; 40(6):555-68. PubMed ID: 25352227
[TBL] [Abstract][Full Text] [Related]
7. [Parathyroid hormone (PTH)/PTH-related peptide (PTHrP) receptor and the signal transduction].
Amizuka N; Li M
Nihon Rinsho; 2005 Oct; 63 Suppl 10():278-83. PubMed ID: 16279648
[No Abstract] [Full Text] [Related]
8. Parathyroid hormone.
Leung EKY
Adv Clin Chem; 2021; 101():41-93. PubMed ID: 33706890
[TBL] [Abstract][Full Text] [Related]
9. Rare genetic disorders that impair parathyroid hormone synthesis, secretion, or bioactivity provide insights into the diagnostic utility of different parathyroid hormone assays.
Höppner J; Jüppner H
Curr Opin Nephrol Hypertens; 2024 Jul; 33(4):375-382. PubMed ID: 38701324
[TBL] [Abstract][Full Text] [Related]
10. Current Nomenclature of Pseudohypoparathyroidism: Inactivating Parathyroid Hormone/Parathyroid Hormone-Related Protein Signaling Disorder.
Turan S
J Clin Res Pediatr Endocrinol; 2017 Dec; 9(Suppl 2):58-68. PubMed ID: 29280743
[TBL] [Abstract][Full Text] [Related]
11. Progressive Development of PTH Resistance in Patients With Inactivating Mutations on the Maternal Allele of GNAS.
Usardi A; Mamoune A; Nattes E; Carel JC; Rothenbuhler A; Linglart A
J Clin Endocrinol Metab; 2017 Jun; 102(6):1844-1850. PubMed ID: 28323910
[TBL] [Abstract][Full Text] [Related]
12. Mechanisms of ligand binding to the parathyroid hormone (PTH)/PTH-related protein receptor: selectivity of a modified PTH(1-15) radioligand for GalphaS-coupled receptor conformations.
Dean T; Linglart A; Mahon MJ; Bastepe M; Jüppner H; Potts JT; Gardella TJ
Mol Endocrinol; 2006 Apr; 20(4):931-43. PubMed ID: 16339275
[TBL] [Abstract][Full Text] [Related]
13. Vitamin D and dexamethasone inversely regulate parathyroid hormone-induced regulator of G protein signaling-2 expression in osteoblast-like cells.
Hömme M; Schmitt CP; Himmele R; Hoffmann GF; Mehls O; Schaefer F
Endocrinology; 2003 Jun; 144(6):2496-504. PubMed ID: 12746312
[TBL] [Abstract][Full Text] [Related]
14. [Phosphocalcic metabolism: regulation and explorations].
Courbebaisse M; Souberbielle JC
Nephrol Ther; 2011 Apr; 7(2):118-38. PubMed ID: 21273150
[TBL] [Abstract][Full Text] [Related]
15. Pseudohypoparathyroidism type 1B caused by methylation changes at the GNAS complex locus.
Poradosu S; Bravenboer B; Takatani R; Jüppner H
BMJ Case Rep; 2016 May; 2016():. PubMed ID: 27170606
[TBL] [Abstract][Full Text] [Related]
16. PTH, FGF-23, Klotho and Vitamin D as regulators of calcium and phosphorus: Genetics, epigenetics and beyond.
Portales-Castillo I; Simic P
Front Endocrinol (Lausanne); 2022; 13():992666. PubMed ID: 36246903
[TBL] [Abstract][Full Text] [Related]
17. Arrestins in bone.
Bohinc BN; Gesty-Palmer D
Prog Mol Biol Transl Sci; 2013; 118():335-58. PubMed ID: 23764060
[TBL] [Abstract][Full Text] [Related]
18. Salt inducible kinases and PTH1R action.
Yoon SH; Tang CC; Wein MN
Vitam Horm; 2022; 120():23-45. PubMed ID: 35953111
[TBL] [Abstract][Full Text] [Related]
19. Genetic variation in the PTH pathway and bone phenotypes in elderly women: evaluation of PTH, PTHLH, PTHR1 and PTHR2 genes.
Tenne M; McGuigan F; Jansson L; Gerdhem P; Obrant KJ; Luthman H; Akesson K
Bone; 2008 Apr; 42(4):719-27. PubMed ID: 18280230
[TBL] [Abstract][Full Text] [Related]
20. Endogenous ligand recognition and structural transition of a human PTH receptor.
Kobayashi K; Kawakami K; Kusakizako T; Miyauchi H; Tomita A; Kobayashi K; Shihoya W; Yamashita K; Nishizawa T; Kato HE; Inoue A; Nureki O
Mol Cell; 2022 Sep; 82(18):3468-3483.e5. PubMed ID: 35932760
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
